CIK 0000105770 · Large accelerated filer
WEST PHARMACEUTICAL SERVICES INC
Sign in to watch- Ticker
- WST
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- PA
- Entity type
- operating
- EIN
- 231210010
- Phone
- 6105942900
- Business address
- 530 HERMAN O. WEST DRIVE, EXTON, PA, 19341
- Former names
- WEST CO INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,443,749
- in 2 filings, $2.7M under 10b5-1 plans
Net −$5,443,749. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-30 | HAUGEN JANET BRUTSCHEA Director | Grant or award · Phantom Stock Unit | +44 | $370.76 | $16K | 350.87 |
| 2026-09-15 | Favorite Annette F Sr. VP & Chief HR Officer | Option exercise 10b5-1 | +2,524 | $89.64 | $226K | 24,341.81 |
| 2026-09-15 | Favorite Annette F Sr. VP & Chief HR Officer | Sale 10b5-1 | −2,524 | $365.00 | $921K | 21,817.81 |
| 2026-09-15 | Favorite Annette F Sr. VP & Chief HR Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,524 | 0 | ||
| 2026-09-14 | Favorite Annette F Sr. VP & Chief HR Officer | Option exercise 10b5-1 | +2,500 | $89.64 | $224K | 24,317.81 |
| 2026-09-14 | Favorite Annette F Sr. VP & Chief HR Officer | Sale 10b5-1 | −2,500 | $355.00 | $888K | 21,817.81 |
| 2026-09-14 | Favorite Annette F Sr. VP & Chief HR Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,500 | 2,524 | ||
| 2026-09-11 | Favorite Annette F Sr. VP & Chief HR Officer | Option exercise 10b5-1 | +2,500 | $89.64 | $224K | 24,317.81 |
| 2026-09-11 | Favorite Annette F Sr. VP & Chief HR Officer | Sale 10b5-1 | −2,500 | $345.00 | $863K | 21,817.81 |
| 2026-09-11 | Favorite Annette F Sr. VP & Chief HR Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,500 | 5,024 | ||
| 2026-09-08 | Lagarde Michel President and CEO | Grant or award · Stock Option (Right to Buy) | +13,879 | 13,879 | ||
| 2026-09-08 | Lagarde Michel President and CEO | Grant or award · Stock Option (Right to Buy) | +11,081 | 11,081 | ||
| 2026-09-08 | Lagarde Michel President and CEO | Grant or award · Stock Option (Right to Buy) | +12,088 | 12,088 | ||
| 2026-09-08 | Lagarde Michel President and CEO | Grant or award · Rst. Stock Unit | +6,200 | 6,200 | ||
| 2026-09-08 | Lagarde Michel President and CEO | Grant or award · Rst. Stock Unit | +4,950 | 4,950 | ||
| 2026-09-08 | Lagarde Michel President and CEO | Grant or award · Rst. Stock Unit | +3,600 | 3,600 | ||
| 2026-09-08 | Favorite Annette F Sr. VP & Chief HR Officer | Option exercise | +2,817 | $83.47 | $235K | 19,661.55 |
| 2026-09-08 | Favorite Annette F Sr. VP & Chief HR Officer | Sale | −2,817 | $340.81 | $960K | 16,844.55 |
| 2026-09-08 | Favorite Annette F Sr. VP & Chief HR Officer | Option exercise | +2,818 | $83.47 | $235K | 19,662.55 |
| 2026-09-08 | Favorite Annette F Sr. VP & Chief HR Officer | Sale | −2,818 | $340.81 | $960K | 16,844.55 |
Page 1 of 13 · 257 trades